bioMérieux S.A. (BMXMF)

Cost of Revenue

€879.28M

Quarterly · Period ending: · EUR

BMXMF logo

BMXMF Cost of Revenue

Latest reported€879.28M EUR
BMXMF Quarterly Cost of Revenue · EUR (€563.80M → €879.28M)
High-resolution chart · PNG

BMXMF cost of revenue history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

bioMérieux S.A. Cost of Revenue — Quarterly (EUR)
Period endingCost of Revenue (EUR)
879,281,792
1,032,813,026
876,900,000
925,500,000
839,100,000
933,500,000
854,500,000
912,100,000
744,900,000
761,800,000
667,500,000
713,200,000
668,800,000
652,100,000
574,000,000
584,100,000
534,900,000
547,100,000
529,300,000
520,500,000
482,000,000
515,800,000
459,600,000
458,100,000
395,800,000
405,600,000
357,700,000
563,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.